• Release date: September 21, 2021

• Expiration date: September 21, 2023

• Estimated time to complete activity: 3.75 hours

• Jointly provided by Postgraduate Institute for Medicine and CME Science

Course Description

The course is designed to provide the tools for participants to enhance abdominal imaging interpretation skills utilizing the latest imaging technologies. Lectures and cases will cover evidence-based practice techniques and protocols for improved accuracy in abdominal imaging applications.

Objectives

•Describe the imaging anatomy and protocols that are necessary to arrive at a diagnosis of prostate diseases.

•Discuss the treatment of the liver

•Optimize Abdominal Imaging Methods

Faculty

Shreyas Vasanawala, MD/PhD

Shreyas Vasanawala MD/PhD

- William R. Brody Professor of Pediatric Radiology and Child Health

Pricing

$375
Body Imaging Part 4 - Shreyas Vasanawala, MD
3.75 AMA PRA Category 1 Credit(s)™

Refund Policy: Cancellations can only be made within 24 hours of purchase. Please note: If you have applied for CME credit during the 24 hour period “NO” refunds will be available. Refunds will be given less a $100.00 administrative fee.

JA

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CME Science. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

The faculty members have nothing to disclose.

Planners and Managers

The PIM planners and managers have nothing to disclose. The CME Science planners and managers have nothing to disclose.

Method of Participation and Request for Credit

During the period September 21 2021 through September 21 2024, participants must read the learning objectives and faculty disclosures and study the educational activity.

Media

Internet

Computer System Requirements

Any online accessible device.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Computer System Requirements

Any online accessible device.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.